Opus Genetics, Inc. Operating Cash Flow
Opus Genetics, Inc. (IRD) reported Operating Cash Flow of -$24.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Opus Genetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$11.95M.
- Opus Genetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$12.73M.
- Opus Genetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$9.83M.
- Opus Genetics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.16M.
- Opus Genetics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$35.25M.
- Opus Genetics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$25.58M.
- Opus Genetics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$1.11M, a 107.77% decline from fiscal 2022.
- Opus Genetics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $14.31M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$24.68M 10-Q · filed 2026-08-06 | -$34.51M derived: sum of 3 quarters · filed 2026-08-06 | -$40.67M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$12.73M 10-Q · filed 2026-05-12 | -$22.56M derived: sum of 2 quarters · filed 2026-05-12 | -$28.72M derived: sum of 3 quarters · filed 2026-05-12 | -$38.99M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$9.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$15.99M derived: sum of 2 quarters · filed 2026-03-12 | -$26.26M derived: sum of 3 quarters · filed 2026-08-06 | -$35.25M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$6.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$16.43M derived: sum of 2 quarters · filed 2026-08-06 | -$25.42M 10-Q · filed 2025-11-12 | -$32.86M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$10.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$19.26M 10-Q · filed 2026-08-06 | -$26.70M derived: sum of 3 quarters · filed 2026-08-06 | -$31.83M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$8.99M 10-Q · filed 2026-05-12 | -$16.43M derived: sum of 2 quarters · filed 2026-05-12 | -$21.56M derived: sum of 3 quarters · filed 2026-05-12 | -$28.85M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$12.57M derived: sum of 2 quarters · filed 2026-03-12 | -$19.86M derived: sum of 3 quarters · filed 2026-03-12 | -$25.58M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$5.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$12.42M derived: sum of 2 quarters · filed 2025-11-12 | -$18.14M 10-Q · filed 2025-11-12 | -$13.59M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$7.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$13.01M 10-Q · filed 2025-08-13 | -$8.46M derived: sum of 3 quarters · filed 2025-08-13 | -$11.46M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$5.72M 10-Q · filed 2025-05-15 | -$1.17M derived: sum of 2 quarters · filed 2025-05-15 | -$4.17M derived: sum of 3 quarters · filed 2025-05-15 | -$3.18M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.54M derived: sum of 2 quarters · filed 2025-03-31 | $2.53M derived: sum of 3 quarters · filed 2025-03-31 | -$1.11M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.01M derived: sum of 2 quarters · filed 2024-11-12 | -$5.66M 10-Q · filed 2024-11-12 | $23.13M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $989.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$2.66M 10-Q · filed 2024-08-13 | $26.13M derived: sum of 3 quarters · filed 2024-08-13 | $21.64M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$3.65M 10-Q · filed 2024-05-10 | $25.14M derived: sum of 2 quarters · filed 2024-05-10 | $20.65M derived: sum of 3 quarters · filed 2024-05-10 | $16.84M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $28.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $24.29M derived: sum of 2 quarters · filed 2024-03-08 | $20.48M derived: sum of 3 quarters · filed 2024-03-08 | $14.31M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | -$4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$8.31M derived: sum of 2 quarters · filed 2023-11-13 | -$14.48M 10-Q · filed 2023-11-13 | -$20.12M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$3.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$9.98M 10-Q · filed 2023-08-11 | -$15.63M derived: sum of 3 quarters · filed 2023-08-11 | -$19.21M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$6.17M 10-Q · filed 2023-05-15 | -$11.82M derived: sum of 2 quarters · filed 2023-05-15 | -$15.40M derived: sum of 3 quarters · filed 2023-05-15 | -$19.73M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$9.23M derived: sum of 2 quarters · filed 2023-03-30 | -$13.56M derived: sum of 3 quarters · filed 2023-03-30 | -$19.37M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$7.91M derived: sum of 2 quarters · filed 2022-11-04 | -$13.72M 10-Q · filed 2022-11-04 | -$18.08M derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2021-06-30 | -$4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$10.14M 10-Q · filed 2022-08-12 | -$14.50M derived: sum of 3 quarters · filed 2022-08-12 | -$15.55M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$5.81M 10-Q · filed 2022-05-13 | -$10.17M derived: sum of 2 quarters · filed 2022-05-13 | -$11.23M derived: sum of 3 quarters · filed 2022-05-13 | -$11.88M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$5.41M derived: sum of 2 quarters · filed 2022-03-24 | -$6.07M derived: sum of 3 quarters · filed 2022-03-24 | -$6.80M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.71M derived: sum of 2 quarters · filed 2021-11-12 | -$2.44M 10-Q · filed 2021-11-12 | -$4.14M 10-Q · filed 2020-10-29 | $2.53M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$651.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.38M 10-Q · filed 2021-08-12 | -$3.01M 10-Q · filed 2020-08-14 | $3.59M derived: sum of 3 quarters · filed 2021-08-12 | $1.21M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$732.00K 10-Q · filed 2021-05-07 | -$1.22M 10-Q · filed 2020-05-07 | $4.24M derived: sum of 2 quarters · filed 2021-05-07 | $1.86M derived: sum of 3 quarters · filed 2021-05-07 | $55.09K derived: sum of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $2.59M derived: sum of 2 quarters · filed 2021-03-11 | $787.10K derived: sum of 3 quarters · filed 2021-03-11 | -$3.59M 10-K · filed 2021-03-11 | -$10.28M 10-K · filed 2020-02-21 | |||
| 2019-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$4.18M derived: sum of 2 quarters · filed 2020-10-29 | -$8.56M 10-Q · filed 2020-10-29 | -$13.18M derived: sum of 4 quarters · filed 2020-10-29 | ||||
| 2019-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$6.19M 10-Q · filed 2020-08-14 | -$10.81M derived: sum of 3 quarters · filed 2020-08-14 | -$14.97M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$4.38M 10-Q · filed 2020-05-07 | -$9.00M derived: sum of 2 quarters · filed 2020-05-07 | -$13.17M derived: sum of 3 quarters · filed 2020-05-07 | -$17.62M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$8.79M derived: sum of 2 quarters · filed 2020-02-21 | -$13.24M derived: sum of 3 quarters · filed 2020-02-21 | -$18.84M 10-K · filed 2020-02-21 | ||||
| 2018-09-30 | -$4.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$8.62M derived: sum of 2 quarters · filed 2019-11-06 | -$14.22M 10-Q · filed 2019-11-06 | -$17.92M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | -$4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$10.05M 10-Q · filed 2019-08-07 | -$13.76M derived: sum of 3 quarters · filed 2019-08-07 | -$17.20M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$5.60M 10-Q · filed 2019-05-10 | -$9.30M derived: sum of 2 quarters · filed 2019-05-10 | -$12.75M derived: sum of 3 quarters · filed 2019-05-10 | -$16.85M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | -$3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$7.15M derived: sum of 2 quarters · filed 2019-03-07 | -$11.25M derived: sum of 3 quarters · filed 2019-03-07 | -$15.42M 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | -$3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$7.55M derived: sum of 2 quarters · filed 2018-11-02 | -$11.72M 10-Q · filed 2018-11-02 | |||||
| 2017-06-30 | -$4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$8.27M 10-Q · filed 2018-08-03 | ||||||
| 2017-03-31 | -$4.17M 10-Q · filed 2018-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |